NCT07059936View on ClinicalTrials.gov

Predicting Immunotherapy Response and Survival of Liver Cancer Patients Using Artificial Intelligence and Radiomics (Radiology-AI-Liver)

RecruitingOBSERVATIONAL

Enrollment

350

Participants

Timeline

Start Date

July 31, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions

Hepatocellular Carcinoma (HCC)

Trial Locations (1)

430000

RECRUITING

Union Hospital，Tongji Medical College，Huazhong University of Science and Technology, Wuhan

All Listed Sponsors

lead

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

OTHER

NCT07059936 - Predicting Immunotherapy Response and Survival of Liver Cancer Patients Using Artificial Intelligence and Radiomics (Radiology-AI-Liver) | Biotech Hunter | Biotech Hunter